Hoshi Iryo-Sanki (7634) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
22 Jul, 2026Executive summary
Revenue for Q1 FY2026 was ¥3,735 million, up 3.9% year-over-year; operating profit rose 24.8% to ¥380 million; ordinary profit increased 23.8% to ¥395 million; net income attributable to shareholders was ¥269 million, up 27.0%.
Financial highlights
Gross profit for Q1 FY2026 was ¥1,846 million, up from ¥1,802 million year-over-year.
EPS for Q1 FY2026 was ¥86.42, compared to ¥68.13 in the prior year.
Comprehensive income for Q1 FY2026 was ¥472 million, up 23.9% year-over-year.
Outlook and guidance
Full-year FY2026 revenue forecast is ¥15,260 million, up 1.0% year-over-year; operating profit forecast is ¥2,070 million, up 4.4%; net income forecast is ¥1,476 million, up 0.9%.
No changes to previously announced earnings guidance.
Latest events from Hoshi Iryo-Sanki
- Revenue rose 7.7% but profits fell over 20% year-over-year; guidance unchanged.7634
Q1 202522 Jul 2026 - Modest profit growth and stable outlook, with a completed subsidiary merger for efficiency.7634Q2 202522 Jul 2026
- Revenue up 3.1% year-over-year, but profits dipped; outlook and dividend unchanged.7634Q3 202522 Jul 2026
- Modest profit growth driven by home healthcare and medical gas, with stable outlook ahead.7634Q4 202522 Jul 2026
- Revenue up 1.2% year-over-year, operating profit down 1.9%, dividend forecast raised.7634Q2 202622 Jul 2026
- Revenue up 3.2% year-over-year, but profit margins pressured by rising costs.7634Q3 202622 Jul 2026
- Revenue up, profits down; home healthcare strong, outlook modestly positive.7634Q4 202622 Jul 2026